And if we were to get one, which will not happen at least till 2026, then it would be a no brainer for a bigger pharma to run both acne and rosacea phase 3's simultaneously.
Just think if one only is a success.
Makes some recent numbers look pathetic doesnt it.
Now you know what management think when they value themselves so highly.
Food for thought but it won't make you fat. Try roast duck with a nice pinot. Bin Night Romeos tonight with a mate on the big white Gretsch and boy can he play.
And if we were to get one, which will not happen at least till...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $617.9M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 34.3¢ | 32.5¢ | $1.814M | 5.424M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 489055 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 340303 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |